Some Thoughts on the Use of Predictive Probability in Clinical Trials
Li, Heng, Buzoianu, Manuela, Chakraborty, Adrijo, Dong, Li Ming, Ko, Chia-Wen, Li, Xuefeng, Lu, Nelson, Qu, Yanping, Xu, Yunling, Yan, Xu
Published in Therapeutic innovation & regulatory science (01.05.2023)
Published in Therapeutic innovation & regulatory science (01.05.2023)
Get full text
Journal Article
Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical study
Bao, Haifeng, Burke, Patricia A, Huang, Jiaqi, Chen, Xiaoru, Brohawn, Philip Z, Yao, Yihong, Lechleider, Robert J, Sikorski, Robert S, Buzoianu, Manuela, Zhang, Jianliang, Shi, Xiaoqing, Richman, Laura K, Lavallee, Theresa M
Published in PloS one (21.08.2013)
Published in PloS one (21.08.2013)
Get full text
Journal Article
HLA‐Specific Antibodies are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft Dysfunction
Girnita, Alin L., Duquesnoy, Rene, Yousem, Samuel A., Iacono, Aldo T., Corcoran, Timothy E., Buzoianu, Manuela, Johnson, Bruce, Spichty, Kathy J., Dauber, James H., Burckart, Gilbert, Griffith, Bartley P., McCurry, Kenneth R., Zeevi, Adriana
Published in American journal of transplantation (01.01.2005)
Published in American journal of transplantation (01.01.2005)
Get full text
Journal Article
A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma
Hersey, Peter, Sosman, Jeffrey, O'Day, Steven, Richards, Jon, Bedikian, Agop, Gonzalez, Rene, Sharfman, William, Weber, Robert, Logan, Theodore, Buzoianu, Manuela, Hammershaimb, Luz, Kirkwood, John M
Published in Cancer (15.03.2010)
Published in Cancer (15.03.2010)
Get full text
Journal Article
A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
Hersey, Peter, Sosman, Jeffrey, O'Day, Steven, Richards, Jon, Bedikian, Agop, Gonzalez, Rene, Sharfman, William, Weber, Robert, Logan, Theodore, Buzoianu, Manuela, Hammershaimb, Luz, Kirkwood, John M.
Published in Cancer (15.03.2010)
Published in Cancer (15.03.2010)
Get full text
Journal Article
Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors
Annunziata, Christina M., Kohn, Elise C., LoRusso, Patricia, Houston, Nicole D., Coleman, Robert L., Buzoianu, Manuela, Robbie, Gabriel, Lechleider, Robert
Published in Investigational new drugs (01.02.2013)
Published in Investigational new drugs (01.02.2013)
Get full text
Journal Article
Sex-specific Long-term Outcomes of Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation
Jiang, Hongying, Zheng, Qi, Cheng, Yun-Ju, Buzoianu, Manuela, Neubrander, Rachel, Zusterzeel, Robbert, Farb, Andrew, Moscucci, Mauro
Published in Journal of the Society for Cardiovascular Angiography & Interventions (01.01.2023)
Published in Journal of the Society for Cardiovascular Angiography & Interventions (01.01.2023)
Get full text
Journal Article
A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox: Phase I Study in Pediatric Acute Lymphoblastic Leukemia (ALL)
Wayne, Alan S, Bhojwani, Deepa, Silverman, Lewis B., Richards, Kelly, Stetler-Stevenson, Maryalice, Shah, Nirali N, Jeha, Sima, Pui, Ching-Hon, Buzoianu, Manuela, FitzGerald, David J., Kreitman, Robert J., Ibrahim, Ramy, Pastan, Ira
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
A Phase 1 Study of Moxetumomab Pasudotox, An Anti-CD22 Recombinant Immunotoxin, In Relapsed/Refractory Hairy Cell Leukemia (HCL): Updated Results
Kreitman, Robert J., Tallman, Martin S., Coutre, Steven, Robak, Tadeusz, Wilson, Wyndham H., Stetler-Stevenson, Maryalice, Noel, Pierre, FitzGerald, David J., Buzoianu, Manuela, Lechleider, Robert J., Pastan, Ira
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin α v β 3 , ± dacarbazine in patients with stage IV metastatic melanoma
Hersey, Peter, Sosman, Jeffrey, O'Day, Steven, Richards, Jon, Bedikian, Agop, Gonzalez, Rene, Sharfman, William, Weber, Robert, Logan, Theodore, Buzoianu, Manuela, Hammershaimb, Luz, Kirkwood, John M.
Published in Cancer (15.03.2010)
Published in Cancer (15.03.2010)
Get full text
Journal Article
Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma
Moschos, Stergios J, Sander, Cindy A, Wang, Wenjun, Reppert, Shelley L, Drogowski, Laura M, Jukic, Drazen M, Rao, Uma N M, Athanassiou, Charalambos, Buzoianu, Manuela, Mandic, Maja, Richman, Laura, McKinney, LuAnn, Leininger, Joel, Tice, David A, Hammershaimb, Luz, Kirkwood, John M
Published in Journal of immunotherapy (1997) (01.04.2010)
Published in Journal of immunotherapy (1997) (01.04.2010)
Get more information
Journal Article
Phase I Dose-Escalation Study of CAT-8015 (HA22), A CD22-Specific Targeted Immunotoxin, in Relapsed or Refractory Hairy Cell Leukemia
Kreitman, Robert J, Tallman, Martin S., Coutre, Steven, Robak, Tadeusz, Wilson, Wyndham H, Stetler-Stevenson, Maryalice, Noel, Pierre, FitzGerald, David J., Buzoianu, Manuela, Lechleider, Robert, Kaucic, Karen, Pastan, Ira
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article